Package Leaflet: Information for the User
Medical Liquid Oxygen Nippon Gases 99.5% v/v, Cryogenic Medical Gas in Fixed Cryogenic Container
Oxygen
Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.
Contents of the Package Leaflet
Medical Liquid Oxygen Nippon Gases 99.5% v/v, inhalation gas is an inhalation gas supplied in fixed cryogenic containers of various capacities made of stainless steel.
It contains oxygen at a concentration of more than 99.5% v/v.
It does not contain other excipients.
Oxygen is an essential element for the body.
Treatment with oxygen is indicated in the following cases:
Treatment of acute cluster headache attacks (a specific type of headache that causes short but very strong crises on one side of the head).
Do not useMedical Liquid Oxygen Nippon Gases
This medication cannot be used at high pressure in cases of untreated pulmonary collapses (untreated pneumothorax). A pulmonary collapse is an accumulation of gas in the thoracic cavity between the two pulmonary membranes. If you have previously suffered a pulmonary collapse.
Warnings and precautions:
Consult your doctor, pharmacist, or nurse before starting to use Medical Liquid Oxygen Nippon Gases.
You must inform your doctor if you have a chronic pulmonary disease such as bronchitis, emphysema, or asthma, and in severe cases of oxygen deficiency.
No fatty substances (petroleum jelly, ointments, etc.) should be applied to the face, due to the risk of inflammation of this medication (see section 6).
In certain severe cases of oxygen deficiency, after 6 hours of exposure to a concentration of oxygen of 100%, or after 24 hours of exposure to a concentration of oxygen above 70%, pulmonary or neurological toxicity may appear (see sections 3 and 6). Therefore, high concentrations should be used for as short a time as possible and controlled by analyzing the gases in the arterial blood, while measuring the inhaled oxygen concentration. It is advisable to use the lowest effective dose to maintain the partial arterial oxygen pressure (PaO2) at 50-60 mm Hg (i.e., 5.65-7.96 kPa) and, after 24 hours of exposure, to maintain, as far as possible, an oxygen concentration below 45%.
Oxygen is not a substitute for other medications prescribed for the treatment of cluster headaches.
Precautions for use:
Children:
In newborns, especially if they are premature, eye damage (retrolental fibroplasia) may occur with certain concentrations of oxygen.
For infants who need a concentration above 30%, the partial arterial oxygen pressure (PaO2) should be regularly controlled so that it does not exceed 100 mm Hg (i.e., 13.3 kPa).
Other medications and Medical Liquid Oxygen Nippon Gases
Inform your doctor or pharmacist that you are taking, have recently taken, or may need to take any other medication.
The toxicity of oxygen may be increased by: corticosteroids, some cancer medications, paraquat, sympathomimetics, X-rays, or in cases of hyperthyroidism or deficiency of vitamins C and E or glutathione.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist before using this medication.
This medication has been widely used without any notable effects.
Driving and using machines
There is no data on the effect of Medical Liquid Oxygen Nippon Gases on driving and using machines.
Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Your doctor will determine the correct dose of Medical Liquid Oxygen Nippon Gases and administer it through a system suitable for your needs, ensuring the supply of the correct amount of oxygen.
If you think the effect of Medical Liquid Oxygen Nippon Gases is too strong or too weak, inform your doctor.
If you use more Medical Liquid Oxygen Nippon Gases than you should:
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
In case of overdose, the inhaled oxygen concentration should be decreased, and symptomatic treatment is recommended.
Like all medications, Medical Liquid Oxygen Nippon Gases may cause side effects, although not everyone will experience them.
In chronic respiratory failure, in particular, there is a possibility of apnea.
Inhaling high concentrations of oxygen can cause small lung collapses.
Administering oxygen at high pressures can cause injuries to the inner ear (which may pose a risk of rupturing the eardrum), sinuses, lungs (which may pose a risk of pneumothorax).
Convulsive crises have been reported after administration of oxygen with a concentration of 100% for more than 6 hours, particularly with high-pressure administration.
Lung injuries may occur after administration of oxygen concentrations above 80%.
Patients undergoing high-pressure oxygen therapy in chambers may experience claustrophobia crises.
Other side effects in children
In newborns, especially if they are premature, exposed to high concentrations of oxygen (FiO2 > 40%; PaO2 above 80 mm Hg, i.e., 10.64 kPa) or for a prolonged period (more than 10 days at a FiO2 concentration > 30%), there is a risk of retinopathies, which appear between 3 and 6 weeks after treatment, and may experience regression or cause retinal detachment, or even permanent blindness. If you experience side effects, consult your doctor or pharmacist or nurse, even if they are not listed in this package leaflet.
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist or nurse, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the packaging.
The expiration date is the last day of the month indicated.
All regulations regarding the handling of pressure vessels must be followed.
Regarding storage and transportation, the following must be taken into account:
Storage of containers:
Containers must be installed in well-ventilated areas, and the installation site must be surrounded by a fence that can be locked, and the enclosure must be kept clean and free of flammable materials.
Containers must be protected from heat sources or ignition, temperatures equal to or above 50°C, and combustible materials, and the entry of water into the containers must be prevented.
Transportation of containers:
Do not park vehicles in the oxygen transfer area.
.
Composition of Medical Liquid Oxygen Nippon Gases:
Appearance of the product and contents of the packaging
The packaging is fixed cryogenic containers of various capacities made of stainless steel.
The different sizes are classified by their approximate capacity in liters of liquid oxygen and the gas content at a supply pressure of 1 bar at 15°C:
Not all packaging sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
NIPPON GASES ESPAÑA S.L.U.
C/Orense, 11
28020 Madrid.
Spain
Manufacturer:
NIPPON GASES ESPAÑA S.L.U.
Ctra. Madrid-Irun, Km. 418
20212 Olaberria (Guipúzcoa)
Spain
Or
NIPPON GASES ESPAÑA S.L.U.
Pasaje del Metal 14-15
Pol. Ind. San Vicente
08755 Castellbisbal (Barcelona)
Spain
Or
NIPPON GASES ESPAÑA S.L.U.
C/ Gavilanes, 12
Pol. Ind. La Estación
28320 Pinto (Madrid)
Spain
Or
NIPPON GASES ESPAÑA S.L.U.
Pol. Ind. Somonte II
33393 Gijón (Asturias)
Spain
Or
SE CARBUROS METÁLICOS S.A.
C/ Aragón 300, 08009 Barcelona
Spain
Or
ANDALUZA DE GASES S.A (AGSA)
Pol. Ind. Hacienda de Dolores, Crta Sevilla-Málaga km 6,3
41500 Alcalá de Guadaira, Sevilla.
Spain
Or
GASES OXINORTE A.I.E C/ Buen Pastor s/n
48903 Baracaldo (Vizcaya) Spain
Or
SOCIEDAD PORTUGUESA DE OXIGENIO, LDA (SPO)
Rua Professor Antonio Marques, 99. Apartado 1188- Lugar de São Frutuoso-Folgosa
4425-390 Maia, Portugal
Date of the last revision of this package leaflet: August 2019
Detailed information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)
------------------------------------------------------------------------------------------------------------------------
This information is intended only for healthcare professionals.
Instructions for use/manipulation
Do not smoke.
Do not approach an open flame.
Do not grease.
For the specific case of liquid oxygen, additional particularities of the product must be considered, which must be taken into account as precautions for its use and handling:
Medical oxygen containers are exclusively reserved for therapeutic use.
To avoid any incidents, it is necessary to strictly follow the following instructions:
.